Light chain deposition disease with renal involvement: clinical characteristics and prognostic factors
Top Cited Papers
- 1 December 2003
- journal article
- research article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 42 (6) , 1154-1163
- https://doi.org/10.1053/j.ajkd.2003.08.040
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A multicenter phase II trial of 4′-iodo-4′-deoxydoxorubicin (IDOX) in primary amyloidosis (AL)Amyloid, 2002
- The patient with insidious chronic renal failure and the patient with the nephrotic syndrome--two manifestations of a protean and not so rare diseaseNephrology Dialysis Transplantation, 1996
- Intensive Therapy in AL Amyloidosis and Light-Chain Deposition DiseaseAnnals of Internal Medicine, 1995
- Overrepresentation of the VϰIV subgroup in light chain deposition diseaseImmunology Letters, 1994
- Structure of a monoclonal kappa chain of the V kappa IV subgroup in the kidney and plasma cells in light chain deposition disease.Journal of Clinical Investigation, 1991
- Monoclonal Immunoglobulin Deposition Disease: Light Chain and Light and Heavy Chain Deposition Diseases and Their Relation to Light Chain AmyloidosisAnnals of Internal Medicine, 1990
- Light-chain deposition disease: Its relation with AL-type amyloidosisKidney International, 1984
- Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain depositionThe American Journal of Medicine, 1980
- Manifestations of systemic light chain depositionThe American Journal of Medicine, 1976